77 related articles for article (PubMed ID: 23500665)
1. Optimization of brain targeted gallic acid nanoparticles for improved antianxiety-like activity.
Nagpal K; Singh SK; Mishra DN
Int J Biol Macromol; 2013 Jun; 57():83-91. PubMed ID: 23500665
[TBL] [Abstract][Full Text] [Related]
2. Nanoparticle mediated brain targeted delivery of gallic acid: in vivo behavioral and biochemical studies for improved antioxidant and antidepressant-like activity.
Nagpal K; Singh SK; Mishra DN
Drug Deliv; 2012 Nov; 19(8):378-91. PubMed ID: 23173579
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle mediated brain targeted delivery of gallic acid: in vivo behavioral and biochemical studies for protection against scopolamine-induced amnesia.
Nagpal K; Singh SK; Mishra DN
Drug Deliv; 2013; 20(3-4):112-9. PubMed ID: 23651033
[TBL] [Abstract][Full Text] [Related]
4. Antianxiety-like activity of gallic acid in unstressed and stressed mice: possible involvement of nitriergic system.
Dhingra D; Chhillar R; Gupta A
Neurochem Res; 2012 Mar; 37(3):487-94. PubMed ID: 22033862
[TBL] [Abstract][Full Text] [Related]
5. Influence of the formulation on the maximum tolerated doses of brain targeted nanoparticles of gallic acid by oral administration in Wistar rats.
Nagpal K; Singh SK; Mishra D
J Pharm Pharmacol; 2013 Dec; 65(12):1757-64. PubMed ID: 24236986
[TBL] [Abstract][Full Text] [Related]
6. Optimization of brain targeted chitosan nanoparticles of Rivastigmine for improved efficacy and safety.
Nagpal K; Singh SK; Mishra DN
Int J Biol Macromol; 2013 Aug; 59():72-83. PubMed ID: 23597710
[TBL] [Abstract][Full Text] [Related]
7. GABAergic and nitriergic modulation by curcumin for its antianxiety-like activity in mice.
Gilhotra N; Dhingra D
Brain Res; 2010 Sep; 1352():167-75. PubMed ID: 20633542
[TBL] [Abstract][Full Text] [Related]
8. Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology.
Mittal G; Carswell H; Brett R; Currie S; Kumar MN
J Control Release; 2011 Mar; 150(2):220-8. PubMed ID: 21111014
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity enhancement in the colorimetric detection of lead(II) ion using gallic acid-capped gold nanoparticles: improving size distribution and minimizing interparticle repulsion.
Huang KW; Yu CJ; Tseng WL
Biosens Bioelectron; 2010 Jan; 25(5):984-9. PubMed ID: 19782557
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of St. John's wort (Hypericum perforatum) extract on 72-hour sleep deprivation-induced anxiety-like behavior and oxidative damage in mice.
Kumar A; Singh A
Planta Med; 2007 Oct; 73(13):1358-64. PubMed ID: 17918039
[TBL] [Abstract][Full Text] [Related]
11. Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery.
Dhawan S; Kapil R; Singh B
J Pharm Pharmacol; 2011 Mar; 63(3):342-51. PubMed ID: 21749381
[TBL] [Abstract][Full Text] [Related]
12. Locomotor damage and brain oxidative stress induced by lead exposure are attenuated by gallic acid treatment.
Reckziegel P; Dias VT; Benvegnú D; Boufleur N; Silva Barcelos RC; Segat HJ; Pase CS; Dos Santos CM; Flores EM; Bürger ME
Toxicol Lett; 2011 May; 203(1):74-81. PubMed ID: 21402136
[TBL] [Abstract][Full Text] [Related]
13. Zein/Phospholipid Composite Nanoparticles for Successful Delivery of Gallic Acid into aHSCs: Influence of Size, Surface Charge, and Vitamin A Coupling.
Radwan SAA; El-Maadawy WH; Yousry C; ElMeshad AN; Shoukri RA
Int J Nanomedicine; 2020; 15():7995-8018. PubMed ID: 33116514
[TBL] [Abstract][Full Text] [Related]
14. Grafting of gallic acid onto chitosan nano particles enhances antioxidant activities in vitro and protects against ochratoxin A toxicity in catfish (Clarias gariepinus).
Abdel-Wahhab MA; Aljawish A; Kenawy AM; El-Nekeety AA; Hamed HS; Abdel-Aziem SH
Environ Toxicol Pharmacol; 2016 Jan; 41():279-88. PubMed ID: 26774075
[TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
[TBL] [Abstract][Full Text] [Related]
16. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.
Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B
Brain Res; 2008 Mar; 1200():159-68. PubMed ID: 18291351
[TBL] [Abstract][Full Text] [Related]
17. In vivo uptake and acute immune response to orally administered chitosan and PEG coated PLGA nanoparticles.
Semete B; Booysen LI; Kalombo L; Venter JD; Katata L; Ramalapa B; Verschoor JA; Swai H
Toxicol Appl Pharmacol; 2010 Dec; 249(2):158-65. PubMed ID: 20851137
[TBL] [Abstract][Full Text] [Related]
18. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.
Zhang L; Yao J; Zhou J; Wang T; Zhang Q
Int J Pharm; 2013 Jan; 441(1-2):654-64. PubMed ID: 23117024
[TBL] [Abstract][Full Text] [Related]
19. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
Venishetty VK; Chede R; Komuravelli R; Adepu L; Sistla R; Diwan PV
Colloids Surf B Biointerfaces; 2012 Jun; 95():1-9. PubMed ID: 22463845
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
Parikh T; Bommana MM; Squillante E
Eur J Pharm Biopharm; 2010 Mar; 74(3):442-50. PubMed ID: 19941957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
